Free Trial
NASDAQ:ISRG

Intuitive Surgical Q2 2025 Earnings Report

Intuitive Surgical logo
$512.06 -13.99 (-2.66%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$510.82 -1.24 (-0.24%)
As of 07/11/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical EPS Results

Actual EPS
N/A
Consensus EPS
$1.92
Beat/Miss
N/A
One Year Ago EPS
N/A

Intuitive Surgical Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.35 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Intuitive Surgical Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Tuesday, July 22, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Intuitive Surgical Earnings Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Intuitive Surgical: A Leadership That Is Hard To Extirpate
Intuitive Surgical, Inc.: Vessel Sealer Curved receives FDA clearance
See More Intuitive Surgical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Intuitive Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intuitive Surgical and other key companies, straight to your email.

About Intuitive Surgical

Intuitive Surgical (NASDAQ:ISRG) is a pioneer in the design, development and manufacture of robotic-assisted surgical systems aimed at enabling minimally invasive surgery. Headquartered in Sunnyvale, California, the company’s flagship offering is the da Vinci Surgical System, which integrates advanced robotics, 3D visualization and ergonomic surgeon controls to facilitate precision procedures. Intuitive also offers the Ion endoluminal system for minimally invasive biopsy in lung procedures, as well as a suite of specialized instruments, accessories and maintenance services that support a broad range of clinical applications.

The da Vinci Surgical System comprises a surgeon console, patient-side cart and vision cart, allowing surgeons to perform complex procedures through small incisions with enhanced dexterity and control. Intuitive’s EndoWrist instruments replicate the natural motion of the human wrist, while its proprietary 3D high-definition camera provides detailed visualization of the surgical field. Beyond hardware, the company delivers training modules, performance tracking tools and ongoing technical support to help hospitals and surgical teams optimize outcomes and streamline workflow.

Since receiving initial FDA clearance in 2000, Intuitive Surgical has expanded its footprint across more than 70 countries, with regional operations spanning North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. Its systems are used in specialties including urology, gynecology, general surgery, thoracic, cardiac and bariatric surgery. Through strategic partnerships with healthcare institutions and academic medical centers, the company continues to foster clinical research, training programs and product innovations in robotic surgery.

Founded in 1995 by Frederic Moll, John Freund and Robert Younge, Intuitive Surgical has grown from a small start-up into a leader in surgical robotics. The company is led by President and Chief Executive Officer Gary S. Guthart, under whose tenure Intuitive has introduced newer generations of its da Vinci platform and diversified into image-guided therapy. With a focus on improving patient outcomes and reducing recovery times, Intuitive remains at the forefront of medical technology innovation in the global healthcare industry.

View Intuitive Surgical Profile

More Earnings Resources from MarketBeat